ALONGI, FILIPPO
 Distribuzione geografica
Continente #
NA - Nord America 17.592
AS - Asia 8.545
EU - Europa 8.463
SA - Sud America 2.183
AF - Africa 185
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 14
Totale 36.998
Nazione #
US - Stati Uniti d'America 17.323
SG - Singapore 3.084
CN - Cina 2.276
DE - Germania 2.018
BR - Brasile 1.833
PL - Polonia 1.472
UA - Ucraina 1.360
HK - Hong Kong 1.274
RU - Federazione Russa 922
GB - Regno Unito 804
VN - Vietnam 680
IT - Italia 520
FR - Francia 387
TR - Turchia 372
IE - Irlanda 333
FI - Finlandia 284
BD - Bangladesh 253
IN - India 151
AR - Argentina 130
CA - Canada 127
SE - Svezia 120
ID - Indonesia 78
MX - Messico 75
IQ - Iraq 72
EC - Ecuador 53
ZA - Sudafrica 52
CO - Colombia 50
AT - Austria 44
PK - Pakistan 39
NL - Olanda 37
SA - Arabia Saudita 36
JP - Giappone 33
MA - Marocco 32
BE - Belgio 31
ES - Italia 28
VE - Venezuela 27
KE - Kenya 23
UZ - Uzbekistan 23
PE - Perù 22
PY - Paraguay 22
CL - Cile 20
EG - Egitto 17
IL - Israele 17
CZ - Repubblica Ceca 16
JO - Giordania 16
TN - Tunisia 16
EU - Europa 15
CR - Costa Rica 14
JM - Giamaica 14
AU - Australia 13
GR - Grecia 12
AE - Emirati Arabi Uniti 11
BO - Bolivia 11
CH - Svizzera 11
KZ - Kazakistan 11
NP - Nepal 11
TW - Taiwan 11
UY - Uruguay 11
AZ - Azerbaigian 10
DZ - Algeria 10
LB - Libano 10
LT - Lituania 10
OM - Oman 10
TT - Trinidad e Tobago 10
ET - Etiopia 9
BH - Bahrain 8
DO - Repubblica Dominicana 8
PH - Filippine 8
PT - Portogallo 8
NG - Nigeria 7
AL - Albania 6
IR - Iran 6
KG - Kirghizistan 6
MY - Malesia 6
BG - Bulgaria 5
HN - Honduras 5
MU - Mauritius 5
PA - Panama 5
BY - Bielorussia 4
CI - Costa d'Avorio 4
GY - Guiana 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
MD - Moldavia 4
SN - Senegal 4
AM - Armenia 3
DK - Danimarca 3
GE - Georgia 3
GT - Guatemala 3
HU - Ungheria 3
KH - Cambogia 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
BA - Bosnia-Erzegovina 2
EE - Estonia 2
GA - Gabon 2
KR - Corea 2
Totale 36.969
Città #
Fairfield 2.569
Ashburn 1.541
Singapore 1.513
Warsaw 1.467
Hong Kong 1.264
Woodbridge 1.210
Jacksonville 1.071
Seattle 965
Cambridge 926
Houston 900
Wilmington 834
Princeton 611
Dallas 598
The Dalles 582
Chandler 564
Beijing 468
Ann Arbor 411
San Jose 385
New York 340
Dublin 325
Lauterbourg 309
Istanbul 300
Los Angeles 246
Helsinki 235
Nanjing 235
Ho Chi Minh City 228
Des Moines 171
Moscow 150
Dearborn 136
Redondo Beach 130
Hanoi 129
Buffalo 125
San Diego 125
São Paulo 124
Council Bluffs 101
Nürnberg 100
London 92
Nanchang 89
Changsha 84
Chicago 75
Dong Ket 74
Santa Clara 63
Munich 56
Jinan 55
Rio de Janeiro 54
Hebei 53
Shanghai 53
Jiaxing 51
Orem 51
Brooklyn 48
San Francisco 47
Frankfurt am Main 46
Shenyang 46
Nuremberg 43
Brescia 41
Milan 40
Brasília 38
Tianjin 38
Belo Horizonte 37
Phoenix 36
Rome 36
Curitiba 35
Boardman 32
Jakarta 31
Johannesburg 31
Montreal 30
Brussels 29
Hangzhou 29
Kunming 29
Orange 29
Poplar 29
Atlanta 28
Kocaeli 28
Denver 27
Tokyo 27
Kilburn 26
North York 26
Westminster 26
Guangzhou 25
Mexico City 25
Zhengzhou 24
Chennai 23
Dhaka 23
Haiphong 23
Lappeenranta 23
Romola 23
Fortaleza 22
Tashkent 22
Toronto 22
Nairobi 21
Porto Alegre 21
Salt Lake City 21
Baghdad 20
Da Nang 20
Kyiv 20
Stockholm 20
Turku 20
Goiânia 19
Salvador 19
Vienna 19
Totale 23.701
Nome #
1.5 T MR-guided and daily adapted SBRT for prostate cancer: Feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment 395
Weekly Cisplatin and Volumetric-Modulated Arc Therapy With Simultaneous Integrated Boost for Radical Treatment of Advanced Cervical Cancer in Elderly Patients: Feasibility and Clinical Preliminary Results 322
1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients 292
Dose-volumerelated dysphagia after constrictor muscles definition in head and neck cancer intensitymodulated radiation treatment 269
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: The point of view of the radiation oncologist 258
1.5 T MR-Guided Daily Adapted SBRT on Lymph Node Oligometastases from Prostate Cancer 255
SBRT and extreme hypofractionation: A new era in prostate cancer treatments? 251
Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique 250
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: Role of local treatments 249
Postoperative breast radiotherapy after neoadjuvant chemotherapy: which uncertainties still remain? 244
Dose variability in different lymph node levels during locoregional breast cancer irradiation: the impact of deep-inspiration breath hold 243
Radiotherapy in patients with connective tissue diseases 237
Real-time intra-fraction motion management in breast cancer radiotherapy: Analysis of 2028 treatment sessions 232
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 220
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 210
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 208
MR-guidance in clinical reality: Current treatment challenges and future perspectives 205
(Ga-68)-PSMA-PET/CT for the detection of postoperative prostate cancer recurrence: Possible implications on treatment volumes for radiation therapy 201
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial 190
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 189
Mastectomy or breast-conserving therapy for early breast cancer in real-life clinical practice: outcome comparison of 7565 cases 185
ONE SHOT - single shot radiotherapy for localized prostate cancer: Study protocol of a single arm, multicenter phase I/II trial 183
An update on radiation therapy in head and neck cancers 183
Radiotherapy in patients with HIV: current issues and review of the literature 182
Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO) 181
Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study 179
GUROPA survey: genito-urinary radiation oncology prescription attitudes 179
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 176
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 174
Intra-fraction and Inter-fraction analysis of a dedicated immobilization device for intracranial radiation treatment 170
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective 169
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer? 168
Role of radiosurgery/stereotactic radiotherapy in oligometastatic disease: Brain oligometastases 165
[11C]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 165
Re: Giorgio Gandaglia, Alberto Briganti, Noel Clarke, et al. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.01.039. 162
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 162
A plethora of therapeutic opportunities for elderly patients with cancer: A nontrivial choice 162
Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system 161
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 160
11C choline PET guided salvage radiotherapy with volumetric modulation arc therapy and hypofractionation for recurrent prostate cancer after HIFU failure: preliminary results of tolerability and acute toxicity 160
What is changing in radiotherapy for the treatment of locally advanced nonsmall cell lung cancer patients? A review 158
18F-sodium fluoride PET-CT for the assessment of brain metastasis from lung Adenocarcinoma 157
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 157
Optical Surface Scanning for Patient Positioning in Radiation Therapy: A Prospective Analysis of 1902 Fractions 154
Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey 150
Extreme hypofractionation for early prostate cancer: Biology meets technology 149
Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer 149
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis 149
Radiation dose-response relationship for risk of coronary heart disease in survivors of hodgkin lymphoma 149
Interplay effects between dose distribution quality and positioning accuracy in total marrow irradiation with volumetric modulated arc therapy 148
Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer. 148
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 147
Stereotactic precision and conventional radiotherapy evaluation (SPACE)-Trial for medically inoperable Stage I NSCLC: A lost opportunity? 146
Radiotherapy in the multidisciplinary treatment of liver cancer: a survey on behalf of the Italian Association of Radiation Oncology 144
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 142
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 142
Choline-PET in prostate cancer management: The point of view of the radiation oncologist 140
Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature 140
Technical Note: Correction for intra-chamber dose gradients in reference dosimetry of flattening-filter-free MV photon beams 140
Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature. 140
Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study. 139
Cancer Therapy combining high-intensity focused ultrasound and megavoltage radiation 139
From radiobiology to technology: What is changing in radiotherapy for prostate cancer 139
Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: Report of dosimetric and early clinical results in oligometastatic patients 139
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies 138
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 138
Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: Dosimetric impact of an increased near-maximum target dose and of a rectal spacer 138
Watch-and-wait versus surgical resection for patients with rectal cancer 137
Cone-beam computed tomography in lung stereotactic ablative radiation therapy: Predictive parameters of early response 137
Low-dose bath with volumetric modulated arc therapy in breast cancer: "much ado about nothing?" 137
Personalized - Not omitted - Radiation oncology for breast cancer 137
Toxicity of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: A potential comparison bias 136
Neuroendocrine carcinoma of the breast: Current evidence and future perspectives 136
Impact of weight loss in patients with head and neck carcinoma undergoing radiotherapy: Is it an underestimated phenomenon A radiation oncologist's perspective 136
Organ sparing and clinical outcome with step-and-shoot IMRT for head and neck cancer: a mono-institutional experience 135
Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy 135
Prostate cancer as a paradigm of multidisciplinary approach? highlights from the italian young radiation oncologist meeting 135
Predictors of mucositis in oropharyngeal and oral cavity cancer in patients treated with volumetric modulated radiation treatment: A dose-volume analysis 135
Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity 135
Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost 135
Current radiotherapy techniques in NSCLC: challenges and potential solutions 135
Stereotactic radiosurgery for patients with brain metastases 134
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists. 133
Crowd knowledge based community in radiotherapy: In response to Yartev et al 133
Stereotactic radiosurgery for intracranial metastases: Linac-based and gamma-dedicated unit approach 133
Stability and reproducibility of 6013 deep inspiration breath-holds in left-sided breast cancer 132
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial. 130
Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy 130
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 130
The BUONGIORNO project: Burnout syndrome among young italian radiation oncologists 129
Consolidative local therapy in oligometastatic patients 128
Stereotactic body radiotherapy with flattening filter-free beams for prostate cancer: assessment of patient-reported quality of life 128
Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for brain metastases: a dosimetric volumetric-modulated arc therapy study 128
Impact of surface-guided positioning on the use of portal imaging and initial set-up duration in breast cancer patients 128
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO) 128
Three-dimensional conformal versus intensity modulated radiotherapy in breast cancer treatment: is necessary a medical reversal? 128
Impact of 18F-choline PET/CT in the decision-making strategy of treatment volumes in definitive prostate cancer volumetric modulated radiation therapy 127
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 127
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani) 126
Spinal metastases: Is stereotactic body radiation therapy supported by evidences? 126
Totale 16.624
Categoria #
all - tutte 197.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 197.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021340 0 0 0 0 0 0 0 0 0 0 0 340
2021/20222.185 164 407 63 144 18 155 121 215 117 201 158 422
2022/20231.840 359 34 46 145 125 501 6 182 263 25 73 81
2023/20242.079 121 56 120 165 84 300 65 65 622 56 41 384
2024/20254.931 21 29 50 567 658 373 385 183 583 483 1.019 580
2025/202610.462 860 1.491 1.408 1.724 648 544 1.184 375 584 871 507 266
Totale 37.475